share_log

Palisade Bio Q4 EPS $(0.25) Beats $(0.34) Estimate

Palisade Bio Q4 EPS $(0.25) Beats $(0.34) Estimate

Palisade Bio第四季度每股收益美元(0.25美元)超过预期(0.34美元)
Benzinga ·  03/27 08:04

Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.34) by 26.47 percent. This is a 98.45 percent increase over losses of $(16.16) per share from the same period last year.

Palisade Bio(纳斯达克股票代码:PALI)公布的季度亏损为每股0.25美元,比分析师普遍预期的0.34美元(0.34美元)高出26.47%。这比去年同期每股亏损16.16美元(16.16美元)增长了98.45%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发